Jia Bainga Kangbai1,2,3, Christian Heumann4, Michael Hoelscher5, Foday Sahr6,7, Guenter Froeschl5. 1. Center for International Health, University of Munich (LMU), Munich, Germany. Jia.Kangbai@lrz.uni-muenchen.de. 2. Department of Environmental Health Sciences, Njala University, Freetown, Sierra Leone. Jia.Kangbai@lrz.uni-muenchen.de. 3. School of Public Health and Tropical Medicine, Tulane University, New Orleans, USA. Jia.Kangbai@lrz.uni-muenchen.de. 4. Department of Statistics, University of Munich (LMU), Munich, Germany. 5. Division of Infectious Diseases and Tropical Medicine, University Hospital, LMU, Munich, Germany. 6. Department of Microbiology, College of Medicine and Allied Health Sciences, University of Sierra Leone, Freetown, Sierra Leone. 7. The 34 Military Hospital, Wilberforce, Freetown, Sierra Leone.
Abstract
BACKGROUND: The World Health Organization (WHO) declared the West Africa Ebola epidemic as a Public Health Emergency of International Concern in August 2014. During the outbreak period, there were calls for the affected countries to construct Ebola treatment centres and reliable diagnostic laboratories closer to areas of transmission in order to improve the quality care of Ebola Virus Disease (EVD) patients. Delay in seeking treatment has been reported to have led to poor treatment outcome of EVD patients. Sierra Leone recorded more than 8000 probable and confirmed cases and more than 4000 EVD -related deaths nation-wide. METHODS: In this retrospective study, we investigated the effects of treatment delay, length of symptomatic period, EVD patients' sex, age, occupation, region of residence, and clinical characteristics on the treatment outcome of 205 laboratory-confirmed EVD patients who were admitted at the Kenema Government Hospital Ebola Treatment Center (KGHETC) from 13/09/2014-26/11/2014; i.e. during the peak of 2013-2016 EVD outbreak in Sierra Leone. Specifically also, we determined the factors that were associated with the length of stay for EVD treatment for patients who were discharged alive. RESULTS: Majority (66.3%, n = 205/309) of the 309 suspected EVD patients with medical records at the KGHETC triage during the period under review were tested positive for EVD using reverse-transcriptase-polymerase chain reaction (RT-PCR) and had a definitive treatment outcome. Few (33.7%, n = 104/309) suspected EVD patients were not included in our analysis and were classified thus: 29.1% (n = 90/309) suspect EVD cases with negative RT-PCR results, 4.5% (n = 14/309) suspect cases with non-available RT-PCR result. Of the 205 patients, 99 (48.3%) had a fatal outcome. For EVD patients that survived, we recorded a significant association (- 0.06, 95% Confidence Interval (CI) = - 0.14 - - 0.02, p = 0.004) between the Length of Stay (LOS) and for each kilometer travelled to seek treatment at the KGHETC. However, the association between EVD patients that were low skilled workers (- 5.91, 95% CI = - 24.60 - 12.79, p = 0.73), EVD patients who were children and pupils in junior school (- 0.86, 95% CI = - 12.86 - 11.14, p = 0.73), health seeking delay for EVD patients who resided in Kenema District where the KGHETC was located (- 0.49, 95% CI = - 0.12 - 1.09, p = 0.24), sex (- 1.77, 95% CI = - 8.75 - 5.21, p = 0.50), age (0.21, 95% CI = - 0.36 - 0.77, p = 0.57), referral status (1.21, 95% CI = - 17.67 - 20.09, p = 0.89) and the LOS in surviving patients were not statistically significant. CONCLUSION: The high LOS for either treatment outcome for EVD patients that resided in the district in which the EVD treatment facility was located compared to those patients from other districts implies that health authorities should consider intensive health education with high priority given to seeking early EVD treatment, and the construction of strategic ETCs as important components in their response strategy.
BACKGROUND: The World Health Organization (WHO) declared the West Africa Ebola epidemic as a Public Health Emergency of International Concern in August 2014. During the outbreak period, there were calls for the affected countries to construct Ebola treatment centres and reliable diagnostic laboratories closer to areas of transmission in order to improve the quality care of Ebola Virus Disease (EVD) patients. Delay in seeking treatment has been reported to have led to poor treatment outcome of EVDpatients. Sierra Leone recorded more than 8000 probable and confirmed cases and more than 4000 EVD -related deaths nation-wide. METHODS: In this retrospective study, we investigated the effects of treatment delay, length of symptomatic period, EVDpatients' sex, age, occupation, region of residence, and clinical characteristics on the treatment outcome of 205 laboratory-confirmed EVDpatients who were admitted at the Kenema Government Hospital Ebola Treatment Center (KGHETC) from 13/09/2014-26/11/2014; i.e. during the peak of 2013-2016 EVD outbreak in Sierra Leone. Specifically also, we determined the factors that were associated with the length of stay for EVD treatment for patients who were discharged alive. RESULTS: Majority (66.3%, n = 205/309) of the 309 suspected EVDpatients with medical records at the KGHETC triage during the period under review were tested positive for EVD using reverse-transcriptase-polymerase chain reaction (RT-PCR) and had a definitive treatment outcome. Few (33.7%, n = 104/309) suspected EVDpatients were not included in our analysis and were classified thus: 29.1% (n = 90/309) suspect EVD cases with negative RT-PCR results, 4.5% (n = 14/309) suspect cases with non-available RT-PCR result. Of the 205 patients, 99 (48.3%) had a fatal outcome. For EVDpatients that survived, we recorded a significant association (- 0.06, 95% Confidence Interval (CI) = - 0.14 - - 0.02, p = 0.004) between the Length of Stay (LOS) and for each kilometer travelled to seek treatment at the KGHETC. However, the association between EVDpatients that were low skilled workers (- 5.91, 95% CI = - 24.60 - 12.79, p = 0.73), EVDpatients who were children and pupils in junior school (- 0.86, 95% CI = - 12.86 - 11.14, p = 0.73), health seeking delay for EVDpatients who resided in Kenema District where the KGHETC was located (- 0.49, 95% CI = - 0.12 - 1.09, p = 0.24), sex (- 1.77, 95% CI = - 8.75 - 5.21, p = 0.50), age (0.21, 95% CI = - 0.36 - 0.77, p = 0.57), referral status (1.21, 95% CI = - 17.67 - 20.09, p = 0.89) and the LOS in surviving patients were not statistically significant. CONCLUSION: The high LOS for either treatment outcome for EVDpatients that resided in the district in which the EVD treatment facility was located compared to those patients from other districts implies that health authorities should consider intensive health education with high priority given to seeking early EVD treatment, and the construction of strategic ETCs as important components in their response strategy.
Authors: Folorunso Oludayo Fasina; Olubukola T Adenubi; Samuel T Ogundare; Aminu Shittu; Dauda G Bwala; Modupe M Fasina Journal: J Infect Dev Ctries Date: 2015-12-30 Impact factor: 0.968
Authors: Elhadj Ibrahima Bah; Marie-Claire Lamah; Tom Fletcher; Shevin T Jacob; David M Brett-Major; Amadou Alpha Sall; Nahoko Shindo; William A Fischer; Francois Lamontagne; Sow Mamadou Saliou; Daniel G Bausch; Barry Moumié; Tim Jagatic; Armand Sprecher; James V Lawler; Thierry Mayet; Frederique A Jacquerioz; María F Méndez Baggi; Constanza Vallenas; Christophe Clement; Simon Mardel; Ousmane Faye; Oumar Faye; Baré Soropogui; Nfaly Magassouba; Lamine Koivogui; Ruxandra Pinto; Robert A Fowler Journal: N Engl J Med Date: 2014-11-05 Impact factor: 91.245
Authors: John S Schieffelin; Jeffrey G Shaffer; Augustine Goba; Michael Gbakie; Stephen K Gire; Andres Colubri; Rachel S G Sealfon; Lansana Kanneh; Alex Moigboi; Mambu Momoh; Mohammed Fullah; Lina M Moses; Bethany L Brown; Kristian G Andersen; Sarah Winnicki; Stephen F Schaffner; Daniel J Park; Nathan L Yozwiak; Pan-Pan Jiang; David Kargbo; Simbirie Jalloh; Mbalu Fonnie; Vandi Sinnah; Issa French; Alice Kovoma; Fatima K Kamara; Veronica Tucker; Edwin Konuwa; Josephine Sellu; Ibrahim Mustapha; Momoh Foday; Mohamed Yillah; Franklyn Kanneh; Sidiki Saffa; James L B Massally; Matt L Boisen; Luis M Branco; Mohamed A Vandi; Donald S Grant; Christian Happi; Sahr M Gevao; Thomas E Fletcher; Robert A Fowler; Daniel G Bausch; Pardis C Sabeti; S Humarr Khan; Robert F Garry Journal: N Engl J Med Date: 2014-10-29 Impact factor: 91.245
Authors: Jeffrey G Shaffer; Donald S Grant; John S Schieffelin; Matt L Boisen; Augustine Goba; Jessica N Hartnett; Danielle C Levy; Rachael E Yenni; Lina M Moses; Mohammed Fullah; Mambo Momoh; Mbalu Fonnie; Richard Fonnie; Lansana Kanneh; Veronica J Koroma; Kandeh Kargbo; Darin Ottomassathien; Ivana J Muncy; Abigail B Jones; Megan M Illick; Peter C Kulakosky; Allyson M Haislip; Christopher M Bishop; Deborah H Elliot; Bethany L Brown; Hu Zhu; Kathryn M Hastie; Kristian G Andersen; Stephen K Gire; Shervin Tabrizi; Ridhi Tariyal; Mathew Stremlau; Alex Matschiner; Darryl B Sampey; Jennifer S Spence; Robert W Cross; Joan B Geisbert; Onikepe A Folarin; Christian T Happi; Kelly R Pitts; F Jon Geske; Thomas W Geisbert; Erica Ollmann Saphire; James E Robinson; Russell B Wilson; Pardis C Sabeti; Lee A Henderson; S Humarr Khan; Daniel G Bausch; Luis M Branco; Robert F Garry Journal: PLoS Negl Trop Dis Date: 2014-03-20
Authors: Michael T Osterholm; Kristine A Moore; Nicholas S Kelley; Lisa M Brosseau; Gary Wong; Frederick A Murphy; Clarence J Peters; James W LeDuc; Phillip K Russell; Michel Van Herp; Jimmy Kapetshi; Jean-Jacques T Muyembe; Benoit Kebela Ilunga; James E Strong; Allen Grolla; Anja Wolz; Brima Kargbo; David K Kargbo; David Avram Sanders; Gary P Kobinger Journal: mBio Date: 2015-02-19 Impact factor: 7.867
Authors: Tasha Stehling-Ariza; Alexander Rosewell; Sahr A Moiba; Brima Berthalomew Yorpie; Kai David Ndomaina; Kai Samuel Jimissa; Eva Leidman; Dingeman J Rijken; Colin Basler; James Wood; Dumbuya Manso Journal: BMC Infect Dis Date: 2016-10-27 Impact factor: 3.090